Video
Katherine Nickels, MD
At the 2014 Annual Meeting of the Child Neurology Society, Dr. Nickels described four recently approved medications for focal epilepsy.
Conference Coverage
-
‘Compelling’ Results for AI EEG to Predict Functional Outcomes -
With Proper Training, AI Can Be a Useful Tool in Epilepsy Management -
Genetic Testing Is Recommended for Adult Patients With Epilepsy -
Alzheimer’s and Epilepsy: Can Shared Molecular Mechanisms Reveal New Opportunities for Epilepsy? -
Despite Few CNS Gene Therapies for Epilepsy, New Research Offers Hope -
Poverty tied to poor cognition in patients with epilepsy -
Genetic testing warranted in epilepsy of unknown origin -
Sleep disorders linked to increased mortality risk in epilepsy -
Noninvasive testing in midlife flags late-onset epilepsy risk -
Novel neural cell therapy: A cure for focal epilepsy?
Literature Review
-
Epilepsy Linked to Higher COVID Hospitalization, Death Rates -
Service Dogs Lead to Fewer Seizures in Treatment-Resistant Epilepsy -
Seizure Risk Is Nearly Double in Patients With MS -
New, Updated Guidelines for Comprehensive Epilepsy Care -
-
RNA therapeutics will ‘change everything’ in epilepsy -
-
Modified Atkins diet beneficial in drug-resistant epilepsy -
-
Strong two-way link between epilepsy and depression
Question 1 of 5